Overview

Flortaucipir PET Imaging in Subjects With FTD

Status:
Completed

Trial end date:
2018-10-24

Target enrollment:

Participant gender:

Summary

This study is designed to assess the usefulness of flortaucipir in Positron Emission Tomography (PET) imaging for subjects diagnosed with Frontotemporal Dementia (FTD).

Phase:

Phase 1

Details

Lead Sponsor:

Avid Radiopharmaceuticals